Alessandra Gaiba

The identification of potent and selective imidazole-based inhibitors of B-Raf kinase

Andrew K. Takle, Murray J. B. Brown, Susannah Davies et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 189 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +11

6-Heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)

Jason Witherington, Vincent Bordas, Alessandra Gaiba et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 85 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +10

(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors

Mark J. Bamford, Michael J. Alberti, Nicholas Bailey et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 43 citations · Full text

-1,2,5-Oxadiazol-3-ylamine Derivatives, Medicinal Chemistry, Medicine +6

The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase

Andrew K. Takle, Mark J. Bamford, Susannah Davies et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 25 citations · Full text

Drug Target, Biochemistry, B-raf Kinase +9

A Versatile and Convenient Synthesis of N-(Tri-i-propylsilyl)- and N-(t-Butyldimethylsilyl)aldimines

Gianfranco Cainelli, Daria Giacomini, Paola Galletti et al. · Synlett · 1996 · 16 citations

Inorganic Synthesis, Engineering, Organic Chemistry +8